Les Echos Régions – The deployment of VistaCare technology in France

2 September 2021by admin-vistacare

Since obtaining CE marking for its controlled atmosphere chronic and acute wound care device in 2018, DTAMedical has made good progress. Founded by François Dufaÿ in Loulle (Jura), the company, which has recruited a managing director, Thierry Sarda, ex-president of the medical devices union, has seen its product referenced in Nantes and AP-HM hospitals. And a clinical study conducted in four hospitals on 30 patients, completed in June and whose results are to be published this week in the journal “Clinical Trials”, showed an 88% efficiency of healing and a reduction of half the treatment time.

“By halving the time required to treat the wound, we reduce pain and the workload of the staff, and we improve the comfort of everyone, not to mention the economic gain,” says François Dufaÿ. VistaCare proposes to treat acute and complex wounds (ulcers, diabetic feet, burns, etc.) in an enclosure designed to optimize healing parameters.

Raising 4 million euros

“The basic principle is to control and modulate the wound atmosphere [humidity and oxygen, temperature], according to a registered concept called “WEC” for “Wound Environment Controlled”, which allows us to develop a real technological platform”, explains Thierry Sarda. The CEO is aiming for 20 hospitals and 300 patient users by the end of 2021, then 150 hospital departments by the end of 2022, and eventually all of the one million patients with complex wounds in France, before expanding internationally.

To read the full article: click here.

 
 
Ce site est réservé aux professionnels de santé.

Êtes-vous un professionnel de santé ?

 
 
The site is reserved for healthcare professionals.

Are you a healthcare professional ?